Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 5
1988 2
1989 1
1990 5
1992 7
1993 3
1994 3
1995 3
1996 3
1997 3
1998 2
1999 6
2000 2
2001 2
2002 1
2003 6
2004 8
2005 9
2006 2
2007 3
2008 9
2009 2
2010 7
2011 11
2012 9
2013 7
2014 12
2015 6
2016 4
2017 4
2018 2
2019 2
2020 6
2021 9
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical rodent models of cardiac fibrosis.
Wang Y, Wang M, Samuel CS, Widdop RE. Wang Y, et al. Among authors: widdop re. Br J Pharmacol. 2022 Mar;179(5):882-899. doi: 10.1111/bph.15450. Epub 2021 May 10. Br J Pharmacol. 2022. PMID: 33973236 Free article. Review.
Non-peptide AT2-receptor agonists.
Steckelings UM, Larhed M, Hallberg A, Widdop RE, Jones ES, Wallinder C, Namsolleck P, Dahlöf B, Unger T. Steckelings UM, et al. Among authors: widdop re. Curr Opin Pharmacol. 2011 Apr;11(2):187-92. doi: 10.1016/j.coph.2010.11.002. Epub 2010 Dec 15. Curr Opin Pharmacol. 2011. PMID: 21167778 Review.
Anti-fibrotic Potential of AT2 Receptor Agonists.
Wang Y, Del Borgo M, Lee HW, Baraldi D, Hirmiz B, Gaspari TA, Denton KM, Aguilar MI, Samuel CS, Widdop RE. Wang Y, et al. Among authors: widdop re. Front Pharmacol. 2017 Aug 31;8:564. doi: 10.3389/fphar.2017.00564. eCollection 2017. Front Pharmacol. 2017. PMID: 28912715 Free PMC article. Review.
Novel approaches for treating hypertension.
Freeman AJ, Vinh A, Widdop RE. Freeman AJ, et al. Among authors: widdop re. F1000Res. 2017 Jan 27;6:80. doi: 10.12688/f1000research.10117.1. eCollection 2017. F1000Res. 2017. PMID: 28184289 Free PMC article. Review.
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.
Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C. Steckelings UM, et al. Among authors: widdop re. Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281. Pharmacol Rev. 2022. PMID: 36180112 Free PMC article. Review.
Update on the angiotensin AT(2) receptor.
McCarthy CA, Widdop RE, Denton KM, Jones ES. McCarthy CA, et al. Among authors: widdop re. Curr Hypertens Rep. 2013 Feb;15(1):25-30. doi: 10.1007/s11906-012-0321-4. Curr Hypertens Rep. 2013. PMID: 23224511 Review.
AT2 receptors: functional relevance in cardiovascular disease.
Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. Jones ES, et al. Among authors: widdop re. Pharmacol Ther. 2008 Dec;120(3):292-316. doi: 10.1016/j.pharmthera.2008.08.009. Epub 2008 Aug 31. Pharmacol Ther. 2008. PMID: 18804122 Free PMC article. Review.
Angiotensin AT2 receptors: cardiovascular hope or hype?
Widdop RE, Jones ES, Hannan RE, Gaspari TA. Widdop RE, et al. Br J Pharmacol. 2003 Nov;140(5):809-24. doi: 10.1038/sj.bjp.0705448. Epub 2003 Oct 6. Br J Pharmacol. 2003. PMID: 14530223 Free PMC article. Review. No abstract available.
162 results